Related Experiment Video
Updated: Jun 22, 2026

Electrocardiogram Recordings in Anesthetized Mice using Lead II
Published on: June 20, 2020
Cardiac arrest from acquired long QT syndrome: a case report
1Saint Mary's Regional Medical Center, 235 W. 6th Street, Reno NV 89503, USA.
Background:
Many classes of medications initiated by clinicians can cause adverse events, such as cardiac disturbances. One such adverse outcome is that of acquired long QT syndrome, which can lead to arrhythmias and sudden death. When health care practitioners were surveyed about their knowledge of this condition, 20% indicated they knew very little about long QT syndromes and more than 30% failed to check on current therapy before prescribing QT-prolonging medications.
Methods:
A case will be presented to illustrate the importance of understanding this syndrome.
Results:
The causes and pathophysiology of acquired long QT syndrome are discussed, and the resources for clinicians to obtain more information and growing number of offending medications leading to acquired long QT syndrome are provided.
Conclusions:
On-going education is needed to heighten awareness in the health care community to prevent the deleterious outcomes associated with medication induced acquired long QT syndrome.
Insights
Healthcare providers need more education on acquired long QT syndrome, a condition caused by medications that can lead to serious cardiac events. Increased awareness can prevent dangerous arrhythmias and sudden death.
Area of Science:
- Clinical Pharmacology
- Cardiology
- Medical Education
Background:
- Medications can cause adverse events, including cardiac disturbances like acquired long QT syndrome.
- Acquired long QT syndrome poses a risk for arrhythmias and sudden cardiac death.
- A significant percentage of healthcare practitioners lack adequate knowledge regarding long QT syndromes and proactive medication review.
Observation:
- A case study will be presented to highlight the clinical significance of understanding acquired long QT syndrome.
- The pathophysiology and etiological factors contributing to acquired long QT syndrome are examined.
- Resources for clinicians to access further information on this condition are provided.
Findings:
- The number of medications known to prolong the QT interval is increasing.
- Clinicians' insufficient knowledge and failure to review current therapies contribute to the risk of acquired long QT syndrome.
- Understanding the causes and mechanisms of acquired long QT syndrome is crucial for patient safety.
Implications:
- Enhanced and continuous education for healthcare professionals is essential.
- Heightened awareness within the medical community can mitigate adverse outcomes associated with drug-induced long QT syndrome.
- Preventing medication-induced acquired long QT syndrome is critical for reducing patient morbidity and mortality.
More Related Videos
08:28Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus
Published on: April 5, 2011
07:15Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
Related Concept Videos
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Dysrhythmias IV: Characteristics of Bradyarrhythmias
Cardiopulmonary Resuscitation IV: Pharmacological Management
Mechanism of Cardiac Arrhythmias
Dysrhythmias II: Classification of Tachyarrhythmias